Insider Transactions Reported by 17 Insiders of Lyra Therapeutics, Inc.

Symbol
LYRA on Nasdaq
Location
480 Arsenal Way, Watertown, MA

Insiders trading volume in the past year

Lyra Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Maria Palasis President & CEO, Director $9.79M -$13.9K -0.14% Oct 1, 2025
Nbvm Gp, Llc 10%+ Owner $7.47M May 31, 2023
Jason Cavalier Chief Financial Officer $4.63M -$6.09K -0.13% Jul 10, 2025
Harlan Waksal Executive Chair, Director $1.59M Dec 9, 2024
Corinne Noyes SVP of Commercial Strategy and Market Development $109K Jan 31, 2023
Robert E. Richard SVP, Technical Operations $88.9K Jan 31, 2023
Perceptive Advisors Llc 10%+ Owner $54.7K -$527K -90.6% Nov 11, 2025
Richard Nieman Chief Medical Officer Jan 30, 2024
John Bishop Chief Technology Officer Jan 30, 2024
James R. Tobin Director May 14, 2025
C. Ann Merrifield Director May 14, 2025
Pamela Nelson SVP, Regulatory Affairs Feb 12, 2022
W. Bradford Smith Director May 14, 2025
Edward T. Anderson Director, 10%+ Owner Jun 30, 2023
nancy snyderman Director May 14, 2025
Konstantin Poukalov Director Jun 13, 2024
Michael Seth Altman Director Jun 13, 2024

Recent Insider Transactions by Companies or Individuals for Lyra Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.